Connect with us

National

AstraZeneca COVID Vaccine Effective in Late Trials – WebMD

Overall, the vaccine protected against symptomatic disease in 70% of cases, according to a team led by researchers from Oxford University in England.

Published

on

post featured image

By Robert PreidtHealthDay Reporter
TUESDAY, Dec. 8, 2020 (HealthDay News) — AstraZeneca’s COVID-19 vaccine is safe and effective, new data from late-stage trials shows.
Overall, the vaccine protected against symptomatic disease in 70% of cases, according to a team led by researchers from Oxford University in England. Among study volunteers who got a half dose and then a full dose, the rate was 90%, while the rate was 62% in those given two full doses.
“Our findings indicate that our vaccine’s efficacy…

Click here to view the original article.

Safety Mate